NanoViricides Announces $3.8 Million Registered Direct Offering
NanoViricides Inc (NYSE: NNVC) has announced a registered direct offering of 2.52 million common shares or pre-funded warrants, along with accompanying warrants to purchase an additional 2.52 million shares. The transaction is expected to raise $3.8 million and was entered into with a single institutional investor. The company's stock price declined following the announcement, reflecting market sentiment around equity dilution from such offerings. This financing move aims to support ongoing operations or development efforts for NanoViricides' antiviral therapies.
Tickers: $NNVC
Topics: registered direct offering securities purchase agreement stock offering